Cerner (NASDAQ:CERN) Now Covered by Analysts at began coverage on shares of Cerner (NASDAQ:CERNGet Rating) in a research note published on Sunday. The brokerage issued a buy rating on the stock.

Separately, Argus lowered Cerner from a buy rating to a hold rating in a report on Monday, April 11th. Eight investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of Hold and a consensus price target of $89.14.

Shares of CERN opened at $94.92 on Friday. The business has a 50-day moving average of $94.43 and a 200 day moving average of $92.83. Cerner has a fifty-two week low of $69.08 and a fifty-two week high of $95.40. The firm has a market cap of $27.92 billion, a P/E ratio of 47.70, a price-to-earnings-growth ratio of 2.37 and a beta of 0.77. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.77 and a current ratio of 1.79.

Cerner (NASDAQ:CERNGet Rating) last announced its quarterly earnings data on Tuesday, May 3rd. The company reported $0.78 earnings per share for the quarter, topping the consensus estimate of $0.75 by $0.03. The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.47 billion. Cerner had a return on equity of 22.86% and a net margin of 10.15%. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.76 EPS. As a group, research analysts predict that Cerner will post 3.14 earnings per share for the current fiscal year.

In related news, CAO Michael R. Battaglioli sold 5,288 shares of the business’s stock in a transaction that occurred on Wednesday, May 4th. The stock was sold at an average price of $94.09, for a total value of $497,547.92. Following the completion of the sale, the chief accounting officer now owns 3,412 shares in the company, valued at approximately $321,035.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.12% of the company’s stock.

A number of hedge funds have recently made changes to their positions in CERN. IFS Advisors LLC bought a new stake in Cerner in the fourth quarter valued at approximately $31,000. MCF Advisors LLC purchased a new position in shares of Cerner during the first quarter valued at approximately $39,000. TAP Consulting LLC purchased a new position in shares of Cerner during the fourth quarter valued at approximately $46,000. Retirement Planning Co of New England Inc. purchased a new position in shares of Cerner during the fourth quarter valued at approximately $51,000. Finally, Perkins Coie Trust Co increased its stake in shares of Cerner by 78.0% during the first quarter. Perkins Coie Trust Co now owns 541 shares of the company’s stock valued at $51,000 after buying an additional 237 shares during the period. Hedge funds and other institutional investors own 82.23% of the company’s stock.

Cerner Company Profile (Get Rating)

Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Further Reading

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with's FREE daily email newsletter.